Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
    • Eddie’s Story
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

    research

    • Home
    • research
    A group of medical professionals in lab coats examines and discusses X-ray images on a wall. One person points at the images while holding a tablet, and others listen and take notes.
    Healthcare, Research

    UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    January 21, 2026 ayushis Comments Off on UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    UI Health Care has begun treating eligible patients with synovial sarcoma using a new form of immunotherapy known as T cell receptor (TCR) therapy. This treatment approach represents an important step forward in expanding access to innovative options for people facing advanced synovial sarcoma. A targeted immune-based approach TCR therapy is designed to help the […]

    A male doctor in a white coat points at chest X-rays on a screen while explaining them to a female colleague in a medical setting. The doctor holds a tablet in his other hand.
    Latest News, Research

    Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma

    January 12, 2026 ayushis Comments Off on Prasterone (DHEA) for Metastatic or Unresectable Synovial Sarcoma

    Researchers have studied prasterone—also known as DHEA (dehydroepiandrosterone)—as a potential treatment option for people with synovial sarcoma that has spread (metastatic) or cannot be removed through surgery. This clinical study was designed to better understand the safety of prasterone, determine appropriate dosing, and explore whether it could help slow or control disease progression. This trial […]

    A man in a gray suit sits in a modern, well-lit office lounge. Text on the image reads: "Dr. Theodore Laetsch, Lead Investigator & Medical Director, SSF." Blue chairs and large windows are in the background.
    CHOP, Dr. Theodore Laetsch

    Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

    September 29, 2025 joshs Comments Off on Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

    The Synovial Sarcoma Foundation is pleased to highlight a significant milestone at the Children’s Hospital of Philadelphia (CHOP), where pediatric oncologist and Synovial Sarcoma Foundation Board Member, Dr. Theodore W. Laetsch, has been awarded a prestigious $1 million multi-year grant from the National Cancer Institute (NCI). This funding aims to accelerate research and treatment development […]

    A doctor in a white coat with a stethoscope around their neck holds a digital tablet, standing near a window. Only the upper body is visible. Another hand is blurred in the foreground.
    Research, Latest News

    New Market Insights Highlight Growth in Synovial Sarcoma Treatments

    September 10, 2025 joshs Comments Off on New Market Insights Highlight Growth in Synovial Sarcoma Treatments

    The Synovial Sarcoma Foundation is committed to staying informed on the latest research and developments in this rare and aggressive cancer. A recent market report indicates that the global synovial sarcoma market is projected to grow significantly, reaching an estimated USD 420 million by 2034 — up from USD 245 million in 2024, at a […]

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (9)
    • Dr. Theodore Laetsch (3)
    • Education (17)
    • Europe Expansion (1)
    • Healthcare (9)
    • Latest News (10)
    • Programs (1)
    • Rare Cancer (6)
    • Rare Cancer Funding (1)
    • Research (17)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (4)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • Two doctors examine X-ray images of a human skull, one in profile and one facing forward, while discussing the results in a well-lit medical setting.
      Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis
    • A collage of conference scenes: group photo, small group with certificate, speakers at podiums, attentive audience in a tiered auditorium, and conference banners displayed.
      Synovial Sarcoma Foundation Wins First Place at the 16th Annual SPAGN Conference
    • A collage with two photos: on the left, three people pose and smile outdoors by the ocean and rocky coastline; on the right, a person stands in front of a colorful wall display titled "A Journey of the Heart.
      Synovial Sarcoma Foundation Welcomes Lucia and Roberto Belluco to the Board of Directors

    Tags

    Advocacy in Action Afami-cel biomarker testing biomarker testing synovial sarcoma CHOP clinical trials rare cancer FDA approved cancer therapy fungal infection immunotherapy metastatic synovial sarcoma lung new treatments for synovial sarcoma pediatric synovial sarcoma pericardial synovial sarcoma Rare Cancer rare cancer clinical trials Rare Cancer Europe rare cancer research rare cardiac tumor rare disease drug development rare disease funding rare fungal infections in cancer patients rare pediatric cancer rare soft tissue sarcoma research soft tissue sarcoma symptoms soft tissue sarcoma testing solitary fibrous tumor SPAGN SS18-SSX translocation SS18::SSX STAT6 marker SFT Synovial Sarcoma synovial sarcoma clinical trials synovial sarcoma diagnosis Synovial Sarcoma Europe Synovial Sarcoma Foundation synovial sarcoma in children Synovial Sarcoma Italy synovial sarcoma research synovial sarcoma symptoms synovial sarcoma treatment targeted therapy T Cell TECELRA webinar

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    1025 Thomas Jefferson St. NW, Suite W-3200, Washington DC 20007
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch